296 related articles for article (PubMed ID: 36160754)
1. Systemic ASBT inactivation protects against liver damage in obstructive cholestasis in mice.
Kunst RF; de Waart DR; Wolters F; Duijst S; Vogels EW; Bolt I; Verheij J; Beuers U; Oude Elferink RPJ; van de Graaf SFJ
JHEP Rep; 2022 Nov; 4(11):100573. PubMed ID: 36160754
[TBL] [Abstract][Full Text] [Related]
2. Combined inhibition of bile salt synthesis and intestinal uptake reduces cholestatic liver damage and colonic bile salts in mice.
Kunst RF; Bolt I; van Dasselaar RDJ; Nijmeijer BA; Beuers U; Oude Elferink RPJ; van de Graaf SFJ
JHEP Rep; 2024 Jan; 6(1):100917. PubMed ID: 38074508
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of intestinal bile acid absorption improves cholestatic liver and bile duct injury in a mouse model of sclerosing cholangitis.
Baghdasaryan A; Fuchs CD; Österreicher CH; Lemberger UJ; Halilbasic E; Påhlman I; Graffner H; Krones E; Fickert P; Wahlström A; Ståhlman M; Paumgartner G; Marschall HU; Trauner M
J Hepatol; 2016 Mar; 64(3):674-81. PubMed ID: 26529078
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of the renal apical sodium dependent bile acid transporter prevents cholemic nephropathy in mice with obstructive cholestasis.
Ghallab A; González D; Strängberg E; Hofmann U; Myllys M; Hassan R; Hobloss Z; Brackhagen L; Begher-Tibbe B; Duda JC; Drenda C; Kappenberg F; Reinders J; Friebel A; Vucur M; Turajski M; Seddek AL; Abbas T; Abdelmageed N; Morad SAF; Morad W; Hamdy A; Albrecht W; Kittana N; Assali M; Vartak N; van Thriel C; Sous A; Nell P; Villar-Fernandez M; Cadenas C; Genc E; Marchan R; Luedde T; Åkerblad P; Mattsson J; Marschall HU; Hoehme S; Stirnimann G; Schwab M; Boor P; Amann K; Schmitz J; Bräsen JH; Rahnenführer J; Edlund K; Karpen SJ; Simbrunner B; Reiberger T; Mandorfer M; Trauner M; Dawson PA; Lindström E; Hengstler JG
J Hepatol; 2024 Feb; 80(2):268-281. PubMed ID: 37939855
[TBL] [Abstract][Full Text] [Related]
5. Differential and organ-specific functions of organic solute transporter α and β in experimental cholestasis.
van de Wiel SMW; Porteiro B; Belt SC; Vogels EWM; Bolt I; Vermeulen JLM; de Waart DR; Verheij J; Muncan V; Oude Elferink RPJ; van de Graaf SFJ
JHEP Rep; 2022 May; 4(5):100463. PubMed ID: 35462858
[TBL] [Abstract][Full Text] [Related]
6. Boosting mitochondria activity by silencing MCJ overcomes cholestasis-induced liver injury.
Iruzubieta P; Goikoetxea-Usandizaga N; Barbier-Torres L; Serrano-Maciá M; Fernández-Ramos D; Fernández-Tussy P; Gutiérrez-de-Juan V; Lachiondo-Ortega S; Simon J; Bravo M; Lopitz-Otsoa F; Robles M; Ferre-Aracil C; Varela-Rey M; Elguezabal N; Calleja JL; Lu SC; Milkiewicz M; Milkiewicz P; Anguita J; Monte MJ; Marin JJG; López-Hoyos M; Delgado TC; Rincón M; Crespo J; Martínez-Chantar ML
JHEP Rep; 2021 Jun; 3(3):100276. PubMed ID: 33997750
[TBL] [Abstract][Full Text] [Related]
7. Effects of apical sodium-bile acid transporter inhibitor and obeticholic acid co-treatment in experimental non-alcoholic steatohepatitis.
Matye DJ; Qin X; Hasan MN; Gu L; Clayton YD; Li F; Li T
Liver Res; 2022 Dec; 6(4):276-283. PubMed ID: 36819659
[TBL] [Abstract][Full Text] [Related]
8. Mouse organic solute transporter alpha deficiency enhances renal excretion of bile acids and attenuates cholestasis.
Soroka CJ; Mennone A; Hagey LR; Ballatori N; Boyer JL
Hepatology; 2010 Jan; 51(1):181-90. PubMed ID: 19902485
[TBL] [Abstract][Full Text] [Related]
9. Serotonin protects mouse liver from cholestatic injury by decreasing bile salt pool after bile duct ligation.
Jang JH; Rickenbacher A; Humar B; Weber A; Raptis DA; Lehmann K; Stieger B; Moritz W; Soll C; Georgiev P; Fischer D; Laczko E; Graf R; Clavien PA
Hepatology; 2012 Jul; 56(1):209-18. PubMed ID: 22290718
[TBL] [Abstract][Full Text] [Related]
10. Obeticholic acid protects against lithocholic acid-induced exogenous cell apoptosis during cholestatic liver injury.
Lu Q; Zhu Y; Wang C; Zhang R; Miao Y; Chai Y; Jiang Z; Yu Q
Life Sci; 2024 Jan; 337():122355. PubMed ID: 38104861
[TBL] [Abstract][Full Text] [Related]
11. Loss of apical sodium bile acid transporter alters bile acid circulation and reduces biliary damage in cholangitis.
Meadows V; Marakovits C; Ekser B; Kundu D; Zhou T; Kyritsi K; Pham L; Chen L; Kennedy L; Ceci L; Wu N; Carpino G; Zhang W; Isidan A; Meyer A; Owen T; Gaudio E; Onori P; Alpini G; Francis H
Am J Physiol Gastrointest Liver Physiol; 2023 Jan; 324(1):G60-G77. PubMed ID: 36410025
[TBL] [Abstract][Full Text] [Related]
12. Metabolic preconditioning protects BSEP/ABCB11
Fuchs CD; Paumgartner G; Wahlström A; Schwabl P; Reiberger T; Leditznig N; Stojakovic T; Rohr-Udilova N; Chiba P; Marschall HU; Trauner M
J Hepatol; 2017 Jan; 66(1):95-101. PubMed ID: 27593105
[TBL] [Abstract][Full Text] [Related]
13. Deleterious effect of oltipraz on extrahepatic cholestasis in bile duct-ligated mice.
Weerachayaphorn J; Luo Y; Mennone A; Soroka CJ; Harry K; Boyer JL
J Hepatol; 2014 Jan; 60(1):160-6. PubMed ID: 23978715
[TBL] [Abstract][Full Text] [Related]
14. A Current Understanding of Bile Acids in Chronic Liver Disease.
Farooqui N; Elhence A; Shalimar
J Clin Exp Hepatol; 2022; 12(1):155-173. PubMed ID: 35068796
[TBL] [Abstract][Full Text] [Related]
15. Astragalus saponins protect against extrahepatic and intrahepatic cholestatic liver fibrosis models by activation of farnesoid X receptor.
Zhang L; Shi J; Shen Q; Fu Y; Qi S; Wu J; Chen J; Zhang H; Mu Y; Chen G; Liu P; Liu W
J Ethnopharmacol; 2024 Jan; 318(Pt A):116833. PubMed ID: 37400008
[TBL] [Abstract][Full Text] [Related]
16. Nuclear factor-E2-related factor 2 is a major determinant of bile acid homeostasis in the liver and intestine.
Weerachayaphorn J; Mennone A; Soroka CJ; Harry K; Hagey LR; Kensler TW; Boyer JL
Am J Physiol Gastrointest Liver Physiol; 2012 May; 302(9):G925-36. PubMed ID: 22345550
[TBL] [Abstract][Full Text] [Related]
17. Na
Slijepcevic D; Roscam Abbing RLP; Fuchs CD; Haazen LCM; Beuers U; Trauner M; Oude Elferink RPJ; van de Graaf SFJ
Hepatology; 2018 Sep; 68(3):1057-1069. PubMed ID: 29572910
[TBL] [Abstract][Full Text] [Related]
18. A3907, a systemic ASBT inhibitor, improves cholestasis in mice by multiorgan activity and shows translational relevance to humans.
Caballero-Camino FJ; Rodrigues PM; Wångsell F; Agirre-Lizaso A; Olaizola P; Izquierdo-Sanchez L; Perugorria MJ; Bujanda L; Angelin B; Straniero S; Wallebäck A; Starke I; Gillberg PG; Strängberg E; Bonn B; Mattsson JP; Madsen MR; Hansen HH; Lindström E; Åkerblad P; Banales JM
Hepatology; 2023 Sep; 78(3):709-726. PubMed ID: 36999529
[TBL] [Abstract][Full Text] [Related]
19. Ileal Bile Acid Transporter Inhibition for the Treatment of Chronic Constipation, Cholestatic Pruritus, and NASH.
Al-Dury S; Marschall HU
Front Pharmacol; 2018; 9():931. PubMed ID: 30186169
[TBL] [Abstract][Full Text] [Related]
20. Tetrahydroxylated bile acids improve cholestatic liver and bile duct injury in the Mdr2
Fuchs CD; Dixon ED; Hendrikx T; Mlitz V; Wahlström A; Ståhlman M; Scharnagl H; Stojakovic T; Binder CJ; Marschall HU; Trauner M
Hepatol Commun; 2022 Sep; 6(9):2368-2378. PubMed ID: 35691019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
